Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?
- PMID: 16216822
- PMCID: PMC1283183
- DOI: 10.1136/bmj.38611.658947.55
Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?
Abstract
Objectives: To investigate the association between the MTHFR 677C-->T polymorphism and coronary heart disease, assessing small study bias and heterogeneity between studies.
Data sources: Medline and Embase citation searches between January 2001 and August 2004; no language restrictions.
Study selection: Case-control and prospective studies of association between MTHFR 677C-->T variant and myocardial infarction, coronary artery occlusion, or both; 80 studies were included.
Data extraction: Data on genotype frequency and mean homocysteine concentrations by genotype were extracted. Odds ratios were calculated for TT genotype versus CC genotype. Heterogeneity was explored, with stratification by geographical region of the study samples, and meta-regression by difference in mean serum homocysteine concentrations (CC minus TT genotypes) was carried out.
Results: 26,000 cases and 31,183 controls were included. An overall random effects odds ratio of 1.14 (95% confidence intervals 1.05 to 1.24) was found for TT versus CC genotype. There was strong evidence of heterogeneity (P < 0.001, I2 = 38.4%), which largely disappeared after stratification by geographical region. Odds ratios in Europe, Australia, and North America attenuated towards the null, unlike those in the Middle East and Asia.
Conclusions: No strong evidence exists to support an association of the MTHFR 677 C-->T polymorphism and coronary heart disease in Europe, North America, or Australia. Geographical variability may be due to higher folate intake in North America and Europe or to publication bias. The conclusion drawn from previous meta-analyses that folic acid, through lowering homocysteine, has a role in prevention of cardiovascular disease is in some doubt.
Figures
Similar articles
-
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.Lancet. 2011 Aug 13;378(9791):584-94. doi: 10.1016/S0140-6736(11)60872-6. Epub 2011 Jul 29. Lancet. 2011. PMID: 21803414 Free PMC article.
-
MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.JAMA. 2002 Oct 23-30;288(16):2023-31. doi: 10.1001/jama.288.16.2023. JAMA. 2002. PMID: 12387655
-
Role of methylenetetrahydrofolate reductase 677C->T polymorphism in the development of premature myocardial infarction.Atherosclerosis. 2008 Sep;200(1):115-20. doi: 10.1016/j.atherosclerosis.2007.12.016. Epub 2008 Feb 5. Atherosclerosis. 2008. PMID: 18255072
-
The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis.BMC Cancer. 2012 Oct 11;12:467. doi: 10.1186/1471-2407-12-467. BMC Cancer. 2012. PMID: 23057736 Free PMC article. Review.
-
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis.Mol Psychiatry. 2006 Feb;11(2):143-9. doi: 10.1038/sj.mp.4001746. Mol Psychiatry. 2006. PMID: 16172608 Review.
Cited by
-
Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases.Acta Biomed. 2019 Sep 30;90(10-S):7-19. doi: 10.23750/abm.v90i10-S.8748. Acta Biomed. 2019. PMID: 31577248 Free PMC article. Review.
-
A systematic review and meta-analysis expounding the relationship between methylene tetrahydrofolate reductase gene polymorphism and the risk of intracerebral hemorrhage among populations.Front Genet. 2022 Aug 3;13:829672. doi: 10.3389/fgene.2022.829672. eCollection 2022. Front Genet. 2022. PMID: 35991566 Free PMC article.
-
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.Lancet. 2011 Aug 13;378(9791):584-94. doi: 10.1016/S0140-6736(11)60872-6. Epub 2011 Jul 29. Lancet. 2011. PMID: 21803414 Free PMC article.
-
Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.J Rheumatol. 2013 Jun;40(6):809-17. doi: 10.3899/jrheum.121012. Epub 2013 Apr 1. J Rheumatol. 2013. PMID: 23547211 Free PMC article.
-
Genetic and epigenomic footprints of folate.Prog Mol Biol Transl Sci. 2012;108:129-58. doi: 10.1016/B978-0-12-398397-8.00006-X. Prog Mol Biol Transl Sci. 2012. PMID: 22656376 Free PMC article. Review.
References
-
- Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 2002;31: 59-70. - PubMed
-
- Brattstrõm L, Wilcken DEL. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000;72: 315-23. - PubMed
-
- Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72: 324-32. - PubMed
-
- Clarke R. An updated review of the published studies of homocysteine and cardiovascular disease. Int J Epidemiol 2002;31: 70-1. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical